Clinical TrialsSearch results
Number of results: 314
Other
- Phase III trial of doxorubicin / cyclophosphamide (AC), docetaxel (D), and alternating AC and D (AC-D) as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802)
- Patients with Metatatic Breast Cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-09-12
Other
- Phase III trial of neoadjuvant chemotherapy followed by surgery versus surgery alone for bulky stage I/II cervical cancer: Japan Clinical Oncology Group trial (JCOG0102)
- Patients with cervical cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-09-12
Other
- Phase III trial of upfront debulking surgery vs. neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers (JCOG0602, OV-NACTC-P3)
- stage III/IV mullerian carcinomas such as ovarian, tubal and peritoneal carcinomas
- Japan Clinical Oncology Group(JCOG)
- 2006-11-17
Other
- Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0207)
- non-small-cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-09-09
Other
- Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0803/WJOG4307L)
- non-small-cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2008-10-10
Other
- Randomized Controlled Trial to Evaluate Radiotherapy Followed by Endocrine Therapy vs. Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy(JCOG0401)
- prostate cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-07-22
Other
- Randomized Controlled Trial to Evaluate Standard Thoracic Radiotherapy With or Without Concurrent Daily Low-dose Carboplatine in Elderly Patients with Locally Advanced Non-small Cell Lung Cancer(JCOG0301, NCSLC-Elderly-CBDCA-RT Phase III)
- Non-small cell Lung Cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-15
Other
- Randomized phase II/III study of R-CHOP versus weekly rituximab plus CHOP for CD20 positive diffuse large B cell lymphoma (JCOG0601)
- CD20 positive diffuse large B cell lmyphoma
- Japan Clinical Oncology Group(JCOG)
- 2007-12-04
Other
- Randomized phase III study of 5-FU continuous infusion (5-FUci) versus CPT-11 plus CDDP (CP) versus S-1 alone (S-1) in advanced gastric cancer (JCOG9912)
- advanced or recurrent gastric cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-16
Other
- Randomized phase III study of Standard CHOP(S-CHOP) versus Biweekly CHOP(Bi-CHOP) in aggressive Non-Hodgkin's Lymphoma(JCOG9809)
- Non-Hodgkin's lymphoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-04